Open AccessA Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non–small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Author(s) -
Helena A. Yu,
Alexander I. Spira,
Leora Horn,
Jared Weiss,
Howard West,
Giuseppe Giaccone,
Tracey L. Evans,
Ronan J. Kelly,
Bhardwaj Desai,
Andrew Krivoshik,
Diarmuid Moran,
Srinivasu Poondru,
Fei Jie,
Kouji Aoyama,
Anne Keating,
Geoffrey R. Oxnard
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/m336-6m76
Subject(s) - epidermal growth factor receptor , lung , oncology , medicine , epidermal growth factor , cancer research , receptor , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom